Organization

Thomas Hope

6 clinical trials

Clinical trial
A Phase 2 Study of 68Ga-PSMA-11 PET in Patients With Metastatic Castration Resistant Prostate Cancer
Status: Active (not recruiting), Estimated PCD: 2023-09-30
Clinical trial
Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286
Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
Status: Completed, Estimated PCD: 2024-03-31
Clinical trial
Imaging of Solid Tumors Using FAP-2286
Status: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
Status: Not yet recruiting, Estimated PCD: 2028-08-31